Logotype for Oncoinvent

Oncoinvent (ONCIN) investor relations material

Oncoinvent Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Oncoinvent
Q2 2025 earnings summary27 Aug, 2025

Executive summary

  • Advancing Radspherin, a receptor-independent alpha-emitting radiopharmaceutical, with strong efficacy and safety in ovarian and colorectal cancer trials, and ongoing Phase 2 studies addressing high unmet need and limited competition.

  • Merger with BerGenBio approved, creating a combined entity (OncoInvent/Oncoinvent ASA) with a main board listing and a stronger financial platform.

  • Fully underwritten NOK 130 million rights issue and additional fundraising efforts extend the cash runway beyond the Phase 2 interim readout in late 2026.

Financial highlights

  • Sales revenue reached NOK 11.7–11.96 million in H1 2025, up from NOK 67,000 in H1 2024, mainly from lab leasing and services.

  • Operating expenses reduced by 28% to NOK 56.2 million, reflecting strategic cost discipline.

  • EBITDA improved to minus NOK 44.2 million for H1 2025, from minus NOK 78 million a year earlier.

  • Cash and cash equivalents at period end were NOK 77.4 million, up from NOK 35.8 million a year earlier.

  • FTEs reduced to 36 from 51 in 2024.

Outlook and guidance

  • Cash runway, including post-merger rights issue, expected to fund operations beyond the interim Phase 2 ovarian trial readout in late 2026.

  • Focus on accelerating patient recruitment for the ongoing Phase 2 ovarian cancer trial, with key data readouts expected in 2025 and 2026.

  • No material change in operating cash burn anticipated; continued disciplined financial management.

  • Exploring strategic options to further extend cash runway, including partnerships and business development.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Oncoinvent is a biotechnology company focused on the research and development of radiopharmaceuticals for the treatment of cancer. The company specializes in designing targeted therapies that deliver radioactive isotopes directly to cancerous tissues, with the goal of enhancing the precision and effectiveness of treatment while minimizing damage to surrounding healthy cells. Oncoinvent’s core technology platform supports the development of injectable products for intraperitoneal and other localized delivery methods. The company serves the healthcare and pharmaceutical sectors through its proprietary research initiatives. The company is headquartered in Oslo, Norway, and its shares are listed on the NOTC.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage